BIOMAT Database Logo BIOMAT Database Logo

Safety and efficacy of therapeutic monoclonal antibodies in clinical therapy. 1993

J F Bach, and G N Fracchia, and L Chatenoud
INSERM U 25, Hôpital Necker, Paris, France.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

J F Bach, and G N Fracchia, and L Chatenoud
Safety of therapeutic monoclonal antibodies.
October 2010, Current drug safety,
J F Bach, and G N Fracchia, and L Chatenoud
Pre-clinical strategies and safety issues in developing therapeutic monoclonal antibodies.
September 2011, New biotechnology,
J F Bach, and G N Fracchia, and L Chatenoud
Efficacy and safety of PCSK9 monoclonal antibodies.
December 2019, Expert opinion on drug safety,
J F Bach, and G N Fracchia, and L Chatenoud
[Therapeutic monoclonal antibodies in clinical neurology].
June 2010, Der Nervenarzt,
J F Bach, and G N Fracchia, and L Chatenoud
Preclinical and clinical safety of monoclonal antibodies.
July 2007, Drug discovery today,
J F Bach, and G N Fracchia, and L Chatenoud
Clinical pharmacokinetics of therapeutic monoclonal antibodies.
August 2010, Clinical pharmacokinetics,
J F Bach, and G N Fracchia, and L Chatenoud
Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disorders.
December 2021, International immunopharmacology,
J F Bach, and G N Fracchia, and L Chatenoud
Therapeutic Monoclonal Antibodies in the Clinical Laboratory.
November 2017, The journal of applied laboratory medicine,
J F Bach, and G N Fracchia, and L Chatenoud
The unexpected side effects and safety of therapeutic monoclonal antibodies.
January 2014, Drugs of today (Barcelona, Spain : 1998),
J F Bach, and G N Fracchia, and L Chatenoud
Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients With Diabetes.
February 2022, Clinical therapeutics,
Copied contents to your clipboard!